𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression

✍ Scribed by G. Gründer; H. Wetzel; E. Hammes; O. Benkert

Publisher
Springer
Year
1993
Tongue
English
Weight
458 KB
Volume
111
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of low-dose bromocriptine in trea
Effect of low-dose bromocriptine in treatment of psychosis: The dopamine autoreceptor-stimulation strategy
✍ H. Y. Meltzer; T. Kolakowska; A. Robertson; B. J. Tricou 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 534 KB

Bromocriptine (0.5-6.0 mg/day) was administered to seven unmedicated chronic schizophrenic and two schizoaffective patients. Transient slight improvement was noted in four patients and marked improvement in one other. Clinical improvement was associated with nausea and drowsiness. These doses of bro

N-0923, A novel soluble dopamine D2 agon
N-0923, A novel soluble dopamine D2 agonist in the treatment of parkinsonism
✍ Vincent P. Calabrese; K. Alvin Lloyd; Pasquale Brancazio; Eugene Cefali; Pauline 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

N-0923, a novel aminotetralin dopamine D2 agonist, was shown to effectively reverse parkinsonian symptoms in nine dopa/agonist-responsive Parkinson's disease patients. The drug was given up to 4.5 hours by continuous intravenous (i.v.) infusion using an i.v. pump. The onset of anti-parkinsonian effe